Angiotensin II (Ang II) infusions in mice resulted in increased blood pressure, myocardial hypertrophy, and fibrosis, whereas these effects could be counteracted with recombinant human ACE2.24Loss of ACE2 can further exacerbate cardiac damage.25 Here, ACE2 is linked to cardiac hypertrophy.